R&D/Clinical Trials

Latest News

CT-996 Demonstrates Significant Weight Loss in Patients with Obesity and Type 2 Diabetes
CT-996 Demonstrates Significant Weight Loss in Patients with Obesity and Type 2 Diabetes

July 18th 2024

Treatment with CT-996 led to a significant placebo-adjusted mean weight loss of 6.1% within four weeks in participants with obesity but without type 2 diabetes.

Amy Ripston
Driving Sample Excellence: Q&A with Amy Ripston

July 17th 2024

Carvykti Demonstrates Clinically Meaningful Improvement in Patients with Relapsed or Lenalidomide-Refractory Multiple Myeloma After One Line of Prior Therapy
Carvykti Demonstrates Clinically Meaningful Improvement in Patients with Relapsed or Lenalidomide-Refractory Multiple Myeloma After One Line of Prior Therapy

July 2nd 2024

Thomas Rademacher
Preparing for Outbreaks: Q&A with Thomas Rademacher, MD, PhD

June 26th 2024

Hugues Wallemacq, CEO of EXO Biologics.
EXO Biologics CEO Discusses Innovation in Developing Exosome Therapies

June 25th 2024

More News